Thomas W. Pew Jr. is Director at IMARX THERAPEUTICS INC (IMRX). They have made 7 open-market trades across 2 companies since 2007, most recently 2010-05-04.
CIK 0001373960
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $139K since 2007, against 1 sale. Across 6 scored buys the stock is down 9.8% at ninety days, and 10.1 points behind the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 0% | 0% |
| Avg Move | +55.1% | -9.8% | -9.8% |
| Alpha | -65.7% | -10.1% | -10.1% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMRX.OB | SELL | 2010-05-04 | 2010-05-07 | $0.02 | $758 | N/A | N/A | N/A |
| IMRX | BUY | 2007-12-14 | 2007-12-17 | $2.01 | $9K | +55.1% | -9.8% | -9.8% |
| IMRX | BUY | 2007-12-10 | 2007-12-12 | $2.20 | $11K | +55.1% | -9.8% | -9.8% |
| IMRX | BUY | 2007-12-07 | 2007-12-11 | $2.25 | $11K | +55.1% | -9.8% | -9.8% |
| IMRX | BUY | 2007-12-04 | 2007-12-06 | $2.23 | $4K | +55.1% | -9.8% | -9.8% |
| IMRX | BUY | 2007-11-28 | 2007-11-30 | $2.35 | $3K | +55.1% | -9.8% | -9.8% |
| IMRX | BUY | 2007-07-26 | 2007-07-30 | $5.00 | $100K | +55.1% | -9.8% | -9.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.